Abstract
STUDIES of cultured bovine aortic endothelial cells using quantitative chemiluminescence techniques have shown that the amount of nitric oxide released under basal conditions, or in response to either bradykinin or the calcium ionophore A23187 is insufficient to account for the vasorelaxant activities of the endothelium-derived relaxing factor (EDRF) derived from the same source1. This observation contradicts previous suggestions that nitric oxide and EDRF are the same compound2, but may be explained if EDRF is a compound that contains nitric oxide within its structure but is a much more potent vasodilator than nitric oxide. Such a molecule could be one of several nitrosothiols which may yield nitric oxide after a one-electron reduction. The present experiments were carried out to test the possiblity that the biological activities of the endothelium-derived relaxing factor might more closely resemble those of one of these compounds, S-nitrosocysteine, than nitric oxide. Nitric oxide release from cultured bovine aortic endothelial cells was detected by chemiluminescence and bioassay experiments compared the vasodilator potencies of nitric oxide, S-nitrosocysteine, and EDRF. The results suggest that EDRF is much more likely to be a nitrosylated compound such as a nitrosothiol than authentic nitric oxide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Myers, P. R., Guerra, R. Jr & Harrison, D. G. Am. J. Physiol. (Heart Circ. Physiol. 325) 257, H1030–H1037 (1989).
Palmer, R. M., Ferrige, A. G. & Moncada, S. Nature 327, 524–526 (1987).
Walters, C. L., Dyke, C. S., Saxby, M. J. & Walker, R. in Environmental N-Nitroso Compounds Analysis and Formation, 181 (IARC Scientific Publication No. 14, Lyon, 1976).
Gruetter, C. A., Gruetter, D. Y., Lyon, J. E., Kadowitz, P. J. & Ignarro, L. J. J. Pharmac. exp. ther. 219, 181–186 (1981).
Ignarro, L. J., Burke, T. M., Wood, K. S., Wolin, M. S. & Kadowitz, P. J. J. pharmac. exp. Ther. 228, 682–690 (1984).
Rapoport, R. M. & Murad, F. Circ. Res. 52, 352–357 (1983).
Ignarro, L. J. & Gruetter, C. A. Biochim. biophys. Acta 631, 221–231 (1980).
Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J. & Gruetter, C. A. J. Pharmac. exp. Ther. 218, 739–749 (1981).
Jocelyn, P. C. (ed.) Biochemistry of the SH Group (Academic, New York, 1972).
Wei, E. P., Kontos, H. A., Christman, C. W., De Witt, D. S. & Povlishock, J. T. Circ. Res. 57, 781–787 (1985).
Pieper, G. M. & Gross, G. J. Am. J. Physiol. 24, H825–H833 (1988).
Vanbenthuysen, K. M., McMurtry, I. F. & Horowitz, L. D. J. clin. Invest. 79, 265–274 (1987).
Freiman, P. C., Mitchell, G. C., Heistad, D. D., Armstrong, M. L. & Harrison, D. G. Circ. Res. 58, 783–789 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Myers, P., Minor, R., Guerra, R. et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345, 161–163 (1990). https://doi.org/10.1038/345161a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/345161a0
- Springer Nature Limited
This article is cited by
-
NADPH diaphorase detects S-nitrosylated proteins in aldehyde-treated biological tissues
Scientific Reports (2020)
-
Mechanism of Thiol-Induced Nitrogen(II) Oxide Donation by Furoxans: a Quantum-Chemical Study
Chemistry of Heterocyclic Compounds (2015)
-
Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes
Naunyn-Schmiedeberg's Archives of Pharmacology (2012)
-
Oxidative stress and endothelial dysfunction in hypertension
Hypertension Research (2011)
-
Localization and thiol dependancy of endogenous nitro compounds-mediating urethral photo-relaxation
Pflügers Archiv - European Journal of Physiology (2007)